Zacks Company Profile for Bristol Myers Squibb Company (BMY : NYSE) |
|
|
|
Company Description |
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes and sells biopharmaceutical products. It offers products which includes hematology, oncology, cardiovascular and immunology. Bristol-Myers Squibb Company, formerly known as Bristol-Myers Company, is based in New York.
Number of Employees: 32,200 |
|
|
|
Price / Volume Information |
Yesterday's Closing Price: $76.91 |
Daily Weekly Monthly
 |
20 Day Moving Average: 15,496,662 shares |
Shares Outstanding: 2,129.06 (millions) |
Market Capitalization: $163,746.34 (millions) |
Beta: 0.49 |
52 Week High: $78.43 |
52 Week Low: $53.22 |
Short Interest Ratio: |
|
% Price Change |
% Price Change Relative to S&P 500 |
4 Week |
0.21% |
9.80% |
12 Week |
13.86% |
23.54% |
Year To Date |
23.35% |
46.69% |
|
|
|
|
|
Address & Contact Information |
Street Address |
Phone / Fax |
Email Address |
Web URL |
430 E. 29TH STREET 14 FLOOR - NEW YORK,NY 10016 USA |
ph: 212-546-4000 fax: 212-546-4020 |
john.elicker@bms.com |
http://www.bms.com |
|
|
|
General Corporate Information |
Officers
Giovanni Caforio - Chairman and Chief Executive Officer
David V. Elkins - Chief Financial Officer
Karen Santiago - Senior Vice President and Corporate Controller
Peter J. Arduini - Director
Julia A. Haller - Director
|
|
Peer Information
Bristol Myers Squibb Company (CORR.)
Bristol Myers Squibb Company (RSPI)
Bristol Myers Squibb Company (CGXP)
Bristol Myers Squibb Company (BGEN)
Bristol Myers Squibb Company (GTBP)
Bristol Myers Squibb Company (RGRX)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 110122108
SIC: 2834
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 07/27/22
|
|
Share - Related Items
Shares Outstanding: 2,129.06
Most Recent Split Date: 3.00 (2.00:1)
Beta: 0.49
Market Capitalization: $163,746.34 (millions)
|
|
|
|
|
|
EPS Information |
Dividend Information |
Analyst Coverage: No |
Dividend Yield: 2.81% |
Current Fiscal Quarter EPS Consensus Estimate: $1.91 |
Indicated Annual Dividend: $2.16 |
Current Fiscal Year EPS Consensus Estimate: $7.57 |
Payout Ratio: 0.28 |
Number of Estimates in the Fiscal Year Consensus: 6.00 |
Change In Payout Ratio: -0.10 |
Estmated Long-Term EPS Growth Rate: 6.24% |
Last Dividend Paid: 03/31/2022 - $0.54 |
Next EPS Report Date: 07/27/22 |
|
|
|
|